Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $33.15 USD
Change Today -0.84 / -2.47%
Volume 2.4M
HOLX On Other Exchanges
As of 8:10 PM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

hologic inc (HOLX) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/24/15 - $34.20
52 Week Low
04/28/14 - $20.28
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for HOLOGIC INC (HOLX)

hologic inc (HOLX) Related Businessweek News

No Related Businessweek News Found

hologic inc (HOLX) Details

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States and internationally. The company operates in four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment provides Aptima family of assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assays, instrumentation, Invader chemistry platform, ThinPrep system, fetal fibronectin tests, Procleix family of assays, and virology and infectious disease products. The Breast Health segment provides breast imaging and related products and accessories, including digital and film-based mammography systems; computer-aided detection (CAD) for mammography; invasive breast biopsy devices; breast biopsy site markers; breast biopsy guidance systems; and breast brachytherapy products. This segment also offers Dimensions platform, a mammography gantry for 2D and 3D image acquisition and display; C-View that provides a 2D image; breast MRI coils and workstations; and photoconductor coatings. The GYN Surgical segment provides NovaSure system to treat women suffering from abnormal uterine bleeding; and MyoSure system for the hysteroscopic removal of fibroids. The Skeletal Health segment offers discovery and horizon X-ray bone densitometers that assess the bone density of fracture sites; and mini C-arm imaging systems to perform minimally invasive surgical procedures on a patient’s extremities, such as the hand, wrist, knee, foot, and ankle. Hologic, Inc. sells its products through direct sales and service forces, and a network of independent distributors and sales representatives. The company has a strategic alliance with Quest Diagnostics Incorporated. Hologic, Inc. was founded in 1985 and is headquartered in Bedford, Massachusetts.

5,351 Employees
Last Reported Date: 11/20/14
Founded in 1985

hologic inc (HOLX) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $792.3K
Chief Financial Officer
Total Annual Compensation: $147.1K
Chief Operating Officer
Total Annual Compensation: $199.0K
Executive Officer
Total Annual Compensation: $600.0K
Compensation as of Fiscal Year 2014.

hologic inc (HOLX) Key Developments

Luxembourg National Health Laboratory Adopts Hologic's World Class Cervical Health Solutions for Screening Programme

Hologic Inc. announced that Luxembourg's National Health Laboratory, which operates under the Ministry of Health, has successfully implemented the Company's comprehensive product platform for its cervical cancer screening programme. The conversion to Hologic's cervical screening technologies includes the ThinPrep Pap test and imaging system, Aptima HPV assays, the Tomcat pre-analytical processing instrument, and the fully automated, sample-to-answer Panther system.

Hologic Seeks Acquisitions

Hologic Inc. (NasdaqGS:HOLX) is looking for acquisition. Bob McMahon, Chief Financial Officer of Hologic states, "I think we've talked about, are there opportunities for tuck-in acquisitions over time, I think there are opportunities there. They would be that tuck-ins and relatively modest, not anything certainly that we've done in the past at Hologic, but something that can either leverage our existing sales force or channel."

Hologic Inc. Presents at Barclays Global Healthcare Conference, Mar-10-2015 01:05 PM

Hologic Inc. Presents at Barclays Global Healthcare Conference, Mar-10-2015 01:05 PM. Venue: Loews Miami Beach Hotel, 1601 Collins Avenue, Miami, Florida, United States. Speakers: Robert W. McMahon, Chief Financial Officer.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HOLX:US $33.15 USD -0.84

HOLX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
DENTSPLY International Inc $51.10 USD -1.32
MEDNAX Inc $72.83 USD -0.58
Mettler-Toledo International Inc $320.02 USD -2.04
ResMed Inc $64.55 USD -1.15
Cooper Cos Inc/The $180.67 USD -1.08
View Industry Companies

Industry Analysis


Industry Average

Valuation HOLX Industry Range
Price/Earnings 100.0x
Price/Sales 3.7x
Price/Book 4.5x
Price/Cash Flow 19.9x
TEV/Sales 2.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HOLOGIC INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at